Role of Immunoglobulin in Male Infertility

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06423989

Enrollment

Registered

2024-05-21

Start date

2023-04-01

Completion date

2024-12-01

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Subfertility

Brief summary

to investigate the role of IVIG in male infertility and to determine its benefits in term of semen parameters and assisted reproduction outcome

Interventions

COMBINATION_PRODUCTIVIG

treatment of subfertility

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

MALE

Healthy volunteers

Yes

Inclusion criteria

* male patients

Exclusion criteria

* female

Design outcomes

Primary

Measure	Time frame	Description
Semen parameters percentage improvement	6 month	Sperm concentration/ml
Sperm motility	6 month	Percentage active motile sperm
Sperm morphology	6 month	Percentage of normal sperm

Secondary

Measure	Time frame	Description
Assisted Reproduction outcome measure	12 months	Percentage of fertilized

Countries

Pakistan

Contacts

Primary ContactDR Riffat, PhD

rifat.skmc@gmail.com00923225041390

Backup ContactDR Riffat, PhD

riffat.skmc@gmail.com00923225041390

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026